ArticleScientific reports2022

Pemafibrate suppresses NLRP3 inflammasome activation in the liver and heart in a novel mouse model of steatohepatitis-related cardiomyopathy.

Kotaro Kanno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.